Pulse Biosciences, Inc. financial data

Symbol
PLSE on Nasdaq
Location
Hayward, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.22K % +58.4%
Quick Ratio 0.38 %
Debt-to-equity 15 % -49.3%
Return On Equity -69.4 % +29.7%
Return On Assets -60.4 % +20.8%
Operating Margin -91.8K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.8M shares +10.2%
Common Stock, Shares, Outstanding 67.7M shares +10.1%
Entity Public Float 183M USD +47.5%
Common Stock, Value, Issued 68K USD +9.68%
Weighted Average Number of Shares Outstanding, Basic 67.4M shares +10.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 86K USD
Cost of Revenue 279K USD
Research and Development Expense 44.5M USD +50.8%
General and Administrative Expense 31.5M USD +86.4%
Costs and Expenses 79M USD +62.9%
Operating Income (Loss) -78.9M USD -62.7%
Nonoperating Income (Expense) 4.21M USD +75.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -68M USD -54.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -74.7M USD -62%
Earnings Per Share, Basic -1 USD/shares -49.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95.2M USD +20.5%
Accounts Receivable, after Allowance for Credit Loss, Current 15K USD
Inventory, Net 57K USD
Assets, Current 97.2M USD +20.8%
Property, Plant and Equipment, Net 1.06M USD -13.6%
Operating Lease, Right-of-Use Asset 6.32M USD -4.13%
Goodwill 2.79M USD 0%
Other Assets, Noncurrent 705K USD +9.13%
Assets 109M USD +16.9%
Accounts Payable, Current 2.98M USD +72.4%
Employee-related Liabilities, Current 3.59M USD +15.3%
Accrued Liabilities, Current 5.2M USD +36.2%
Contract with Customer, Liability, Current 4K USD -75%
Liabilities, Current 9.7M USD +43.9%
Operating Lease, Liability, Noncurrent 6.37M USD -11.2%
Liabilities 16.1M USD +15.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -446M USD -20.1%
Stockholders' Equity Attributable to Parent 92.7M USD +17.1%
Liabilities and Equity 109M USD +16.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.5M USD -38.3%
Net Cash Provided by (Used in) Financing Activities 14.8M USD +4755%
Net Cash Provided by (Used in) Investing Activities -45K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 67.7M shares +10.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.24M USD
Deferred Tax Assets, Valuation Allowance 99.5M USD +13.3%
Deferred Tax Assets, Gross 101M USD +13%
Operating Lease, Liability 7.89M USD -5.7%
Depreciation 497K USD -7.79%
Payments to Acquire Property, Plant, and Equipment 45K USD +800%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -74.7M USD -62%
Lessee, Operating Lease, Liability, to be Paid 9.59M USD -10.3%
Property, Plant and Equipment, Gross 5.34M USD +4.85%
Operating Lease, Liability, Current 1.52M USD +27.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.3M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.23M USD +12.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.7M USD -26.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.38M USD +12.5%
Deferred Tax Assets, Operating Loss Carryforwards 67M USD +9.63%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 17.4M USD +70.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.08M USD
Operating Lease, Payments 533K USD +13.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 166K USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance 1.6M USD -3.33%
Share-based Payment Arrangement, Expense 23.3M USD +130%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%